RK
Raghad Khaleafi
Technion-Israel Institute of Technology
Israel
Featured talk at CIOC 2027
“Reovirus inhibits tumor antigen presentation leading to impaired cytotoxic-T responses”
Oncolytic viruses are an emerging class of cancer immunotherapies, with several agents approved for clinical use. Mammalian reovirus-based therapies are currently being evaluated…
Read the full abstract →Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.